Investors & Media

Transformative science, targeted medicines

We are working to advanceĀ a deep pipeline of precision therapies, designed to allow patients to live longer, better lives. Our approach combines world-leading expertise in protein kinases with sound execution and an intense focus on discovery.

Investment Calculator

Investment Calculator

Investment Date Original Shares Original Value Current Shares Current Value % Return Split Adjustment Current price
Dec 29, 2017 1,000.00 $75,410.00 1,000.00 $92,290.00 22.38% 1 $92.29

Return calculations do not include reinvested cash dividends.

Data Provided by Refinitiv. Minimum 15 minutes delayed.